BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

900 related articles for article (PubMed ID: 34253904)

  • 1. CD8
    Philip M; Schietinger A
    Nat Rev Immunol; 2022 Apr; 22(4):209-223. PubMed ID: 34253904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The development of CD8 T-cell exhaustion heterogeneity and the therapeutic potentials in cancer.
    Zhang J; Lei F; Tan H
    Front Immunol; 2023; 14():1166128. PubMed ID: 37275913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of oncogenic pathways on evasion of antitumour immune responses.
    Spranger S; Gajewski TF
    Nat Rev Cancer; 2018 Mar; 18(3):139-147. PubMed ID: 29326431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common gamma chain cytokines and CD8 T cells in cancer.
    Shourian M; Beltra JC; Bourdin B; Decaluwe H
    Semin Immunol; 2019 Apr; 42():101307. PubMed ID: 31604532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD8
    Giles JR; Globig AM; Kaech SM; Wherry EJ
    Immunity; 2023 Oct; 56(10):2231-2253. PubMed ID: 37820583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reprogramming responsiveness to checkpoint blockade in dysfunctional CD8 T cells.
    Nelson CE; Mills LJ; McCurtain JL; Thompson EA; Seelig DM; Bhela S; Quarnstrom CF; Fife BT; Vezys V
    Proc Natl Acad Sci U S A; 2019 Feb; 116(7):2640-2645. PubMed ID: 30679280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy.
    Lv M; Chen M; Zhang R; Zhang W; Wang C; Zhang Y; Wei X; Guan Y; Liu J; Feng K; Jing M; Wang X; Liu YC; Mei Q; Han W; Jiang Z
    Cell Res; 2020 Nov; 30(11):966-979. PubMed ID: 32839553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic TCR-MHC (self)-interactions limit the functional potential of TCR affinity-increased CD8 T lymphocytes.
    Duong MN; Erdes E; Hebeisen M; Rufer N
    J Immunother Cancer; 2019 Nov; 7(1):284. PubMed ID: 31690351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem-like exhausted and memory CD8
    Gebhardt T; Park SL; Parish IA
    Nat Rev Cancer; 2023 Nov; 23(11):780-798. PubMed ID: 37821656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rewriting History: Epigenetic Reprogramming of CD8
    Zebley CC; Gottschalk S; Youngblood B
    Trends Immunol; 2020 Aug; 41(8):665-675. PubMed ID: 32624330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organized immune cell interactions within tumors sustain a productive T-cell response.
    Cardenas MA; Prokhnevska N; Kissick HT
    Int Immunol; 2021 Jan; 33(1):27-37. PubMed ID: 32827212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of Memory CD8+ T Cell Differentiation by MicroRNAs.
    Zhang Z; Zhang C; Li F; Zhang B; Zhang Y
    Cell Physiol Biochem; 2018; 47(6):2187-2198. PubMed ID: 30011396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of lymphocyte subsets with efficacy and prognosis of immune checkpoint inhibitor therapy in advanced non-small cell lung carcinoma: a retrospective study.
    Yan Y; Wang X; Liu C; Jia J
    BMC Pulm Med; 2022 Apr; 22(1):166. PubMed ID: 35484541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Checkpoint Blockade Immunotherapy Induces Dynamic Changes in PD-1
    Kurtulus S; Madi A; Escobar G; Klapholz M; Nyman J; Christian E; Pawlak M; Dionne D; Xia J; Rozenblatt-Rosen O; Kuchroo VK; Regev A; Anderson AC
    Immunity; 2019 Jan; 50(1):181-194.e6. PubMed ID: 30635236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reinvigorating exhausted CD8
    Hossain MA; Liu G; Dai B; Si Y; Yang Q; Wazir J; Birnbaumer L; Yang Y
    Med Res Rev; 2021 Jan; 41(1):156-201. PubMed ID: 32844499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD8
    Farhood B; Najafi M; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8509-8521. PubMed ID: 30520029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-infiltrating lymphocytes in the immunotherapy era.
    Paijens ST; Vledder A; de Bruyn M; Nijman HW
    Cell Mol Immunol; 2021 Apr; 18(4):842-859. PubMed ID: 33139907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eomes-Dependent Loss of the Co-activating Receptor CD226 Restrains CD8
    Weulersse M; Asrir A; Pichler AC; Lemaitre L; Braun M; Carrié N; Joubert MV; Le Moine M; Do Souto L; Gaud G; Das I; Brauns E; Scarlata CM; Morandi E; Sundarrajan A; Cuisinier M; Buisson L; Maheo S; Kassem S; Agesta A; Pérès M; Verhoeyen E; Martinez A; Mazieres J; Dupré L; Gossye T; Pancaldi V; Guillerey C; Ayyoub M; Dejean AS; Saoudi A; Goriely S; Avet-Loiseau H; Bald T; Smyth MJ; Martinet L
    Immunity; 2020 Oct; 53(4):824-839.e10. PubMed ID: 33053331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory circuits of T cell function in cancer.
    Speiser DE; Ho PC; Verdeil G
    Nat Rev Immunol; 2016 Oct; 16(10):599-611. PubMed ID: 27526640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD8+ T-cell memory in tumor immunology and immunotherapy.
    Klebanoff CA; Gattinoni L; Restifo NP
    Immunol Rev; 2006 Jun; 211():214-24. PubMed ID: 16824130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.